Drug class
Recombinant human arginase 1 enzyme replacement therapy; arginine-depleting biologic
Mechanism of action
Provides exogenous arginase 1 activity, converting excess arginine to urea and ornithine and thereby lowering plasma arginine in patients with arginase 1 deficiency.
General use cases
- Treatment of hyperargininaemia in adults and paediatric patients aged 2 years and older with arginase 1 deficiency, in conjunction with dietary protein restriction, under the current product label.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
